Global Cell and Gene Therapy Markets Report 2024-2028 Featuring Main Players - Mallinckrodt, Vericel, Gilead Sciences, Pharmicell, and Bristol-Myers Squibb
Dublin, April 03, 2024 (GLOBE NEWSWIRE) -- The "Global Cell and Gene Therapy Market" report has been added to ResearchAndMarkets.com's offering.
The Global Cell and Gene Therapy Market is expected to grow at a compound annual growth rate (CAGR) of 26.40% from 2023 through 2028.
The scope of this study encompasses an investigation of the cell and gene therapy market. The report analyzes cell and gene therapy market based on therapy type, product, application, and region. The publisher determines the current market status in each segment, examines its impact on future needs, and presents growth forecasts over the next five years.
The increasing focus on developing advanced therapies for different therapeutic areas, and growing prevalence of chronic conditions such as cancer and rare diseases, are responsible for market growth.
The market has witnessed approval of therapies in 2022 and 2023. Treatments approved in 2022 include Adstiladrin from Ferring Pharmaceuticals, Hemgenix from CSL Behring and UniQure, Roctavian from Biomarin Pharmaceuticals, Elevidys from Sarepta and Roche, and Upstaza from PTC Therapeutics. Vyjuvek from Krystal Biotech and Lyfgenia from Bluebird Bio were approved in 2023. There are more companies which have submitted biologics license applications for their cell and gene therapy products and the approvals are expected in 2024, thus contributing to the growth of the market.
Products such as Kresladi from Rocket Pharmaceuticals and Fidanacogene elaparvovec from Pfizer have submitted the biologics license application (BLA) and are likely to get approval in March and April 2024.
The report also includes the company profiles of the key players with detailed information about their business segments, financials, product portfolios, and recent developments. The report also provides information on the emerging technologies, and new developments, ESG development and investment outlook.
Report Includes
55 data tables and 26 additional tables
An overview of the global market for cell and gene therapy
Analysis of global market trends, featuring historical revenue data for 2020, 2021, and 2022, estimated figures for 2023, forecasts for 2028, and projections of compound annual growth rates (CAGRs) through 2028
Evaluation of the current market's size and revenue growth prospects specific to cell and gene therapy, along with a market share analysis by therapy type, product, application, and geographic region
An update on recent advances in vector biology, drug delivery technology and gene editing technologies such as CRISPR
Coverage of novel therapeutic products and promising new technologies still in the development and testing stage, with as assessment of the probability that they will be commercialized successfully in the next five years
Discussion on recent approvals, developments, emerging technologies, ESG, and an investment outlook
Profiles of leading market participants, including Mallinckrodt PLC, Vericel Corp., Gilead Sciences Inc., Pharmicell Co. Ltd., and Bristol-Myers Squibb Co.
Company Profiles
Amgen Inc.
Bluebird Bio Inc.
Bristol-Myers Squibb Co.
Dendreon Pharmaceuticals Llc
Ferring Pharmaceuticals
Gilead Sciences Inc.
Iovance Biotherapeutics Inc.
Johnson & Johnson Services Inc.
Krystal Biotech Inc.
Mallinckrodt Plc
Novartis Ag
Orchard Therapeutics Plc.
Pharmicell Co. Ltd.
Uniqure N.V.
Vericel Corp.
Key Topics Covered:
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Market Value
Chapter 2 Market Overview
Cell and Gene Therapy Overview
Regulatory Landscape
U.S. (FDA)
Europe
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Market Restraints
Market Opportunities
Chapter 4 Market Segmentation Analysis
Segmentation Breakdown
Global Market for Cell and Gene Therapy
Market Size and Forecast
Market Analysis
Cell Therapy
Gene-modified Cell Therapy
Gene Therapy
Global Market for Gene-modified Cell Therapy and Gene Therapy by Vector Type
Market Size and Forecast
Market Analysis
Adeno-Associated Viral (AAV) Vectors
Retroviral Vectors
Lentiviral Vectors
Others
Global Market for Cell and Gene Therapy by Drug Product
Market Size and Forecast
Zolgensma
Yescarta
Kymriah
Abecma
Maci
Tecartus
Epicel
Others
Global Market for Cell and Gene Therapy by Application
Market Size and Forecast
Oncology
Rare Diseases
Ophthalmology
Other Therapeutic Areas
Geographic Breakdown
Global Market for Cell and Gene Therapy by Region
Market Size and Forecast
North America
Market Size and Forecast
U.S.
Canada
Mexico
Europe
Market Size and Forecast
Germany
U.K.
France
Rest of Europe
Asia-Pacific
Market Size and Forecast
Japan
China
Australia
Rest of Asia-Pacific
Rest of the World
Market Size and Forecast
Chapter 5 Competitive Intelligence
Investment Outlook
Mergers and Acquisitions
Competitive Landscape: Overview
Market Share Analysis
Strategic Acquisitions and Collaborations
Pipeline Analysis
Chapter 6 Sustainability: An ESG Perspective
Introduction
Conclusion
Chapter 7 Appendix
For more information about this report visit https://www.researchandmarkets.com/r/lou5r9
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900